Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NutriDrink is a range of high-energy, protein-rich oral nutritional supplements (ONS) developed by Nutricia, a subsidiary of Danone. Classified as a Food for Special Medical Purposes (FSMP), it is specifically formulated for the dietary management of patients suffering from disease-related malnutrition or those at risk of nutritional deficiencies due to chronic illnesses such as cancer, chronic obstructive pulmonary disease (COPD), or recovery from major surgery. The product line, which includes variations like NutriDrink Compact and NutriDrink Protein, provides a concentrated source of macronutrients (carbohydrates, proteins, and lipids) and essential micronutrients (vitamins and minerals) in a low-volume format to enhance patient compliance. While its primary application is in reversing weight loss and improving nutritional status in malnourished individuals, it is also utilized in specialized clinical contexts such as sarcopenic obesity and perioperative care to maintain lean body mass and support metabolic health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NutriDrink.